Skip to main content
Clinical Trials/ISRCTN99349253
ISRCTN99349253
Completed
未知

Clinical application of platelet-rich fibrin mixed with Synthetic Hydroxyapatite (Nanobone) material in maxillary sinus augmentation - randomised clinical trial

SUAVEMED0 sites6 target enrollmentMarch 18, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Reduced bone height in the posterior maxilla (1-4 mm)
Sponsor
SUAVEMED
Enrollment
6
Status
Completed
Last Updated
last year

Overview

Brief Summary

2024 Results article in https://doi.org/10.3390/biomedicines12081661 (added 25/07/2024)

Registry
who.int
Start Date
March 18, 2024
End Date
December 17, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
SUAVEMED

Eligibility Criteria

Inclusion Criteria

  • 1\. At least eighteen years old
  • 2\. Have healed edentulous sites on the posterior maxillae region with 5mm or less residual bone height to place implants in need of sinus graft procedure.

Exclusion Criteria

  • 1\. Alcoholism
  • 2\. Smoking
  • 3\. Drug abuse
  • 4\. Diabetes
  • 5\. Heart disease
  • 6\. Bleeding disorders
  • 7\. Weakened immune systems
  • 8\. Radiation exposure
  • 9\. Bleeding disorders
  • 10\. Past or ongoing use of steroids or bisphosphonates

Outcomes

Primary Outcomes

Not specified

Similar Trials